Literature DB >> 12969140

Podocytes that detach in experimental membranous nephropathy are viable.

Arndt T Petermann1, Ron Krofft, Mary Blonski, Keiju Hiromura, Michael Vaughn, Raimund Pichler, Sian Griffin, Takehiko Wada, Jeffrey Pippin, Raghu Durvasula, Stuart J Shankland.   

Abstract

BACKGROUND: Podocyte loss contributes to the development of glomerulosclerosis. Although podocytes have been detected in the urine in certain glomerular diseases, the viability of detached cells is not known.
METHODS: Urine was collected from rats with experimental membranous nephropathy [passive Heymann nephritis (PHN) model], centrifuged, and following resuspension in tissue culture media, cells were seeded onto collagen-coated tissue culture plates. Cells were grown under typical cell culture conditions. Cell number was measured, the cell type was identified by immunostaining with specific antibodies, and cell morphology was assessed by light and electron microscopy.
RESULTS: Cells obtained in the urine from PHN rats were positive for synaptopodin, nephrin, podocin, WT-1, and GLEPP1 (podocyte-specific antigens). When grown ex vivo under cell culture conditions, cells obtained in the urine from PHN rats adhered to tissue culture plates, and expressed podocyte-specific proteins at the mRNA [reverse transcription-polymerase chain reaction (RT-PCR)] and protein (immunostaining) level. Cells did not stain with antibodies to mesangial (OX-7), tubular (Tamm-Horsfall protein) and endothelial (RECA) cells. Electron microscopy showed the presence of foot processes, and podocytes from PHN rats stained positive for C5b-9. Although podocyte number increased transiently during the first 5 days ex vivo, apoptosis increased significantly thereafter, reducing overall cell number.
CONCLUSION: Rats with experimental membranous nephropathy shed podocytes into the urine that attach to tissue culture plates ex-vivo, and proliferate. These results suggest that detached podocytes are viable. These results add new perspectives into our understanding of podocyte loss in the development of glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969140     DOI: 10.1046/j.1523-1755.2003.00217.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  44 in total

1.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

3.  Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

Authors:  Catherine Meyer-Schwesinger; Claudia Lange; Verena Bröcker; Putri Andina Agustian; Putri Andina Agustian; Ulrich Lehmann; Annette Raabe; Martina Brinkmeyer; Eiji Kobayashi; Mario Schiffer; Guntram Büsche; Hans H Kreipe; Friedrich Thaiss; Jan U Becker
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics.

Authors:  Jochen Reiser; Ha Won Lee; Vineet Gupta; Mehmet M Altintas
Journal:  Adv Chronic Kidney Dis       Date:  2017-05       Impact factor: 3.620

Review 5.  Endothelin and the glomerulus in chronic kidney disease.

Authors:  Matthias Barton; Andrey Sorokin
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

6.  De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Authors:  Takamoto Ohse; Michael R Vaughan; Jeffrey B Kopp; Ronald D Krofft; Caroline B Marshall; Alice M Chang; Kelly L Hudkins; Charles E Alpers; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

Review 7.  The pathogenic role of Notch activation in podocytes.

Authors:  Thiruvur Niranjan; Mariana Murea; Katalin Susztak
Journal:  Nephron Exp Nephrol       Date:  2009-03-17

Review 8.  Therapeutic targets in focal and segmental glomerulosclerosis.

Authors:  Peter J Lavin; Rasheed Gbadegesin; Tirupapuliyur V Damodaran; Michelle P Winn
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

9.  Conditionally immortalized human podocyte cell lines established from urine.

Authors:  Toru Sakairi; Yoshifusa Abe; Hiroshi Kajiyama; Linda D Bartlett; Lilian V Howard; Parmijit S Jat; Jeffrey B Kopp
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-02

10.  Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study.

Authors:  Iasmina M Craici; Steven J Wagner; Kent R Bailey; Patrick D Fitz-Gibbon; Christina M Wood-Wentz; Stephen T Turner; Suzanne R Hayman; Wendy M White; Brian C Brost; Carl H Rose; Joseph P Grande; Vesna D Garovic
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.